Pharmaceutical companies have a long history of making data-driven decisions and growing their business with innovative analytics and technology. They’ve been on the leading edge of leveraging new algorithms to design territories, using optimization techniques to design call plans, and applying increasingly sophisticated analytical approaches to determine customer segmentation.

The pharma industry has progressed relatively speedily along the analytics maturity curve, but the analytics landscape is undergoing another massive shift—and this time it’s different. What worked in the past will not easily translate to success in this new realm. 

In this article, you’ll learn how pharma companies can transition to artificial intelligence. Download the article to learn more.